@ % ( @ % CI @-@ ) of patients in the rituximab induction group did not need treatment at @ years , which was significantly more than in the watchful waiting group ( HR @ , @ % CI @-@ ; p < @ ) , but no different compared with the maintenance rituximab group ( @ , @-@ ; p = @ ) .